Multiomics: The Systems Approach Reshaping Drug Discovery and Precision Medicine

The ambitious discipline of multiomics is fundamentally reshaping how researchers understand biology, diagnose disease, and develop therapeutics. By simultaneously studying multiple layers of biological information—from the genome to the proteome and beyond—scientists can now move beyond correlation to identify causation, a shift with profound implications for drug discovery and precision medicine.

"It's like getting a brand-new user manual for cell biology," according to Illumina查看公司主页, which has been advancing multiomic technologies through integrated sequencing platforms and analytical tools.

Defining Multiomics: A Systems Approach

Multiomics is the study of multiple layers of biology—or "omes"—at the same time. The most familiar layer, genomics, provides the comprehensive study of the genome, including gene structure, function, and sequence variations. Yet genomics alone cannot reveal which genes are being expressed at any given moment, how mRNA is spliced, or whether proteins are ultimately synthesized.

Transcriptomics fills some of these gaps by identifying which genes are expressed and resolving splice variants. Spatial transcriptomics further resolves gene expression patterns within intact tissue. Proteomics then reveals which proteins have been synthesized, how they are folded, and what post-translational modifications—such as phosphorylation, glycosylation, or ubiquitination—have occurred. The epigenome, operating like a computer operating system, precisely regulates gene expression in response to environmental cues, making the static genome far more dynamic.

"While each specific ome has its strengths, it can also leave information on the table," Illumina查看公司主页 notes. "A multiomics approach unifies these linked molecular processes, providing more complete insight about the mechanisms that drive biology, health, and disease."

Proteomics: Capturing Real-Time Biology

Among the omics layers, proteomics occupies a distinctive position. If genomics tells researchers what could happen in a cell, proteomics shows what is happening right now. Unlike the relatively static genome, the proteome is highly dynamic, changing across cell types, developmental stages, and environmental conditions.

Proteomics directly measures which proteins are present and at what levels, revealing the true functional state of a cell or tissue. Critically, gene expression does not always correlate with protein abundance, making direct protein measurement essential. The discipline also captures protein structure—where form dictates function—and post-translational modifications that regulate activity, localization, and stability. These modifications are critical for processes like signal transduction and immune response and are only detectable through proteomic analysis.

Research Applications Across Disease Areas

Multiple research teams are already deploying multiomic approaches to tackle complex biomedical challenges. Illumina查看公司主页 and Broad Clinical Labs (搜索)搜索该词条 are collaborating to develop a massive cell atlas aimed at accelerating disease modeling and drug development.

In oncology, Bodour Salhia, PhD, professor of Cancer Biology at USC, combined epigenomics, transcriptomics, and proteomics in an early-stage study to improve accuracy in ovarian cancer (搜索)搜索该疾病 diagnostics. Meanwhile, researchers at Oxford and Cambridge are using multiomics to differentiate CD4 T cells and better understand the immune system.

In neurodegenerative disease, a multiomic research effort led by Emory University is combining genome-wide association studies with proteomics to investigate Alzheimer's pathogenesis. Scientists in Oslo are adding methylation biomarkers to liquid biopsies to improve their diagnostic accuracy.

Implications for Drug Discovery

Multiomics holds tremendous potential to improve drug discovery by enabling researchers to visualize entire biological pathways and study how specific drugs can modulate them. "By comparing disease signatures from different parts of the genome, transcriptome, proteome, and epigenome, researchers can visualize the entire pathway and study how specific drugs can modulate it," according to Illumina查看公司主页.

This integrated view could reveal side effects early in the discovery process rather than in late-stage clinical trials, boost efficacy, and help clinicians understand why some patients respond to a medication while others do not. Investigators can now follow the entire continuum of cellular information—from genome to proteome and beyond—to see how tissues operate.

Technology Platforms Enabling Multiomics

Illumina查看公司主页 supports multiomic research through library preparation workflows, high-throughput sequencing platforms including the NovaSeq X Series, and analytical solutions. The company's 5-base solution provides simultaneous methylation profiling and high-accuracy genetic variant calling. For downstream analysis, DRAGEN secondary analysis and Illumina Connected Multiomics (ICM) harness artificial intelligence to integrate diverse omic datasets and help investigators separate signal from noise.

ICM enables researchers to mix and match data types—genomic, proteomic, spatial, single-cell—for a truly integrated view of biology, while providing critical biological context through curated databases including the Illumina查看公司主页 Correlation Engine.

For multiomic studies, researchers can employ various multimodal techniques: bulk sequencing to pool cell populations and arrive at average measurements, single-cell sequencing for analysis at individual cell resolution, and spatial sequencing for contextual views of cell activity within intact tissues.